Quantitative expression proteomics and phosphoproteomics profile of brain from PINK1 knockout mice: insights into mechanisms of familial Parkinson's disease

Staging of brain pathology related to sporadic Parkinson’s disease

Braak, H., Tredici, K. D., Rüb, U., de Vos, R. A. I., Jansen Steur, E. N. H., & Braak, E. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00065-9 · Cited by 10,777 · see citing works

Neurogenesis in the adult human hippocampus

Eriksson, P. S., Perfilieva, E., Björk-Eriksson, T., Alborn, A.-M., Nordborg, C., Peterson, D. A., & Gage, F. H. (1998) · Nature Medicine · doi:10.1038/3305 · Cited by 6,369 · see citing works

Parkinson's disease: clinical features and diagnosis

Jankovic, J. (2008) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2007.131045 · Cited by 5,720 · see citing works

Hereditary Early-Onset Parkinson's Disease Caused by Mutations in <i>PINK1</i>

Valente, E. M., Abou-Sleiman, P. M., Caputo, V., Muqit, M. M. K., Harvey, K., Gispert, S., Ali, Z., Del Turco, D., Bentivoglio, A. R., Healy, D. G., et al. (2004) · Science · doi:10.1126/science.1096284 · Cited by 3,481 · see citing works

PINK1 Is Selectively Stabilized on Impaired Mitochondria to Activate Parkin

Narendra, D. P., Jin, S. M., Tanaka, A., Suen, D.-F., Gautier, C. A., Shen, J., Cookson, M. R., & Youle, R. J. (2010) · PLoS Biology · doi:10.1371/journal.pbio.1000298 · Cited by 2,944 · see citing works

Non-motor symptoms of Parkinson's disease: diagnosis and management

Chaudhuri, K. R., Healy, D. G., & Schapira, A. H. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(06)70373-8 · Cited by 2,807 · see citing works

Oxidative stress in Parkinson's disease

Jenner, P. (2003) · Annals of Neurology · doi:10.1002/ana.10483 · Cited by 2,053 · see citing works

PINK1 stabilized by mitochondrial depolarization recruits Parkin to damaged mitochondria and activates latent Parkin for mitophagy

Matsuda, N., Sato, S., Shiba, K., Okatsu, K., Saisho, K., Gautier, C. A., Sou, Y.-S., Saiki, S., Kawajiri, S., Sato, F., et al. (2010) · Journal of Cell Biology · doi:10.1083/jcb.200910140 · Cited by 1,969 · see citing works

Mitochondrial dysfunction in Drosophila PINK1 mutants is complemented by parkin

Park, J., Lee, S. B., Lee, S., Kim, Y., Song, S., Kim, S., Bae, E., Kim, J., Shong, M., Kim, J.-M., et al. (2006) · Nature · doi:10.1038/nature04788 · Cited by 1,705 · see citing works

14-3-3 Proteins: Structure, Function, and Regulation

Fu, H., Subramanian, R. R., & Masters, S. C. (2000) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.40.1.617 · Cited by 1,569 · see citing works

Autoradiographic and histological studies of postnatal neurogenesis. IV. Cell proliferation and migration in the anterior forebrain, with special reference to persisting neurogenesis in the olfactory bulb

Altman, J. (1969) · The Journal of Comparative Neurology · doi:10.1002/cne.901370404 · Cited by 1,489 · see citing works

Phosphorylation of Ser-129 Is the Dominant Pathological Modification of α-Synuclein in Familial and Sporadic Lewy Body Disease

Anderson, J. P., Walker, D., Goldstein, J. M., de Laat, R., Banducci, K., Caccavello, R. J., Barbour, R., Huang, J., Kling, K., Lee, M., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m600933200 · Cited by 1,418 · see citing works

A new collection method for the evaluation of nasal mucus proteins

Ruocco, L. A., Fattori, Romanelli, Martelloni, L., Casani, Samolewska, & Rezzonico (1998) · Clinical & Experimental Allergy · doi:10.1046/j.1365-2222.1998.00312.x · Cited by 1,296 · see citing works

Chaperone Suppression of α-Synuclein Toxicity in a <i>Drosophila</i> Model for Parkinson's Disease

Auluck, P. K., Chan, H. Y. E., Trojanowski, J. Q., Lee, V. M.-Y., & Bonini, N. M. (2002) · Science · doi:10.1126/science.1067389 · Cited by 1,227 · see citing works

Peptidyl-prolyl cis-trans isomerase is the cyclosporin A-binding protein cyclophilin

Takahashi, N., Hayano, T., & Suzuki, M. (1989) · Nature · doi:10.1038/337473a0 · Cited by 1,088 · see citing works

Increased Expression of α-Synuclein Reduces Neurotransmitter Release by Inhibiting Synaptic Vesicle Reclustering after Endocytosis

Nemani, V. M., Lü, W., Berge‐Seidl, V., Nakamura, K., Onoa, B., Lee, M. K., Chaudhry, F. A., Nicoll, R. A., & Edwards, R. H. (2010) · Neuron · doi:10.1016/j.neuron.2009.12.023 · Cited by 1,051 · see citing works

Neuroinflammation in Parkinson's disease: Its role in neuronal death and implications for therapeutic intervention

Tansey, M. G., & Goldberg, M. S. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.11.004 · Cited by 1,045 · see citing works

A Structural Scaffolding of Intermediate Filaments in Health and Disease

Fuchs, E. V., & Cleveland, D. W. (1998) · Science · doi:10.1126/science.279.5350.514 · Cited by 1,013 · see citing works

Degradation of oxidized proteins by the 20S proteasome

Davies, K. J. A. (2001) · Biochimie · doi:10.1016/s0300-9084(01)01250-0 · Cited by 849 · see citing works

Parkin is activated by PINK1-dependent phosphorylation of ubiquitin at Ser65

Kazlauskaite, A., Kondapalli, C., Gourlay, R., Campbell, D. G., Ritorto, M. S., Hofmann, K., Alessi, D. R., Knebel, A., Trost, M., & Muqit, M. M. K. (2014) · Biochemical Journal · doi:10.1042/bj20140334 · Cited by 806 · see citing works

Mitochondrial biology and oxidative stress in Parkinson disease pathogenesis

Henchcliffe, C., & Beal, M. F. (2008) · Nature Clinical Practice Neurology · doi:10.1038/ncpneuro0924 · Cited by 786 · see citing works

Loss of PINK1 causes mitochondrial functional defects and increased sensitivity to oxidative stress

Gautier, C. A., Kitada, T., & Shen, J. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0802076105 · Cited by 698 · see citing works

PINK1 is degraded through the N-end rule pathway

Yamano, K., & Youle, R. J. (2013) · Autophagy · doi:10.4161/auto.24633 · Cited by 669 · see citing works

PINK1- and Parkin-mediated mitophagy at a glance

Jin, S. M., & Youle, R. J. (2012) · Journal of Cell Science · doi:10.1242/jcs.093849 · Cited by 631 · see citing works

The V-type H+ ATPase: molecular structure and function,physiological roles and regulation

Beyenbach, K. W., & Wieczorek, H. (2006) · Journal of Experimental Biology · doi:10.1242/jeb.02014 · Cited by 630 · see citing works

Systematic review of incidence studies of Parkinson's disease

Twelves, D., Perkins, K. S. M., & Counsell, C. E. (2002) · Movement Disorders · doi:10.1002/mds.10305 · Cited by 619 · see citing works

Chaperone-Mediated Autophagy Markers in Parkinson Disease Brains

Alvarez‐Erviti, L., Rodríguez-Oroz, M. C., Cooper, J. A. D., Caballero, C., Ferrer, I., Obeso, J. A., & Schapira, A. H. V. (2010) · Archives of Neurology · doi:10.1001/archneurol.2010.198 · Cited by 550 · see citing works

The role of autophagy-lysosome pathway in neurodegeneration associated with Parkinson's disease

Pan, T., Kondo, S., Le, W., & Jankovic, J. J. (2008) · Brain · doi:10.1093/brain/awm318 · Cited by 546 · see citing works

Mechanisms of Synaptic Vesicle Exocytosis

Lin, R. C.-S., & Scheller, R. H. (2000) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.16.1.19 · Cited by 512 · see citing works

Loss-of-Function of Human PINK1 Results in Mitochondrial Pathology and Can Be Rescued by Parkin

Exner, N., Treske, B., Paquet, D., Holmström, K. M., Schiesling, C., Gispert, S., Carballo‐Carbajal, I., Berg, D., Hoepken, H.-H., Gasser, T., et al. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.0719-07.2007 · Cited by 511 · see citing works

PINK1 cleavage at position A103 by the mitochondrial protease PARL

Deas, E., Plun‐Favreau, H., Gandhi, S., Desmond, H., Kjaer, S., Loh, S. H. Y., Renton, A. E., Harvey, R. J., Whitworth, A. J., Martins, L. M., et al. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq526 · Cited by 501 · see citing works

Catalysis of protein folding by prolyl isomerase

Lang, K., Schmid, F. X., & Fischer, G. S. (1987) · Nature · doi:10.1038/329268a0 · Cited by 490 · see citing works

Mitochondrial dysfunction and oxidative stress in Parkinson's disease and monogenic parkinsonism

Hauser, D. N., & Hastings, T. G. (2012) · Neurobiology of Disease · doi:10.1016/j.nbd.2012.10.011 · Cited by 470 · see citing works

Parkinson's disease mutations in PINK1 result in decreased Complex I activity and deficient synaptic function

Morais, V. A., Verstreken, P., Röthig, A. H. J., Smet, J., Snellinx, A., Vanbrabant, M., Haddad, D., Frezza, C., Mandemakers, W. J., Weisenhorn, D. M. V., et al. (2009) · EMBO Molecular Medicine · doi:10.1002/emmm.200900006 · Cited by 444 · see citing works

The role of calmodulin as a signal integrator for synaptic plasticity

Xia, Z., & Storm, D. R. (2005) · Nature reviews. Neuroscience · doi:10.1038/nrn1647 · Cited by 441 · see citing works

Mitochondria and Neuroplasticity

Cheng, A., Hou, Y., & Mattson, M. P. (2010) · ASN NEURO · doi:10.1042/an20100019 · Cited by 433 · see citing works

Cytosolic NADP+-dependent isocitrate dehydrogenase status modulates oxidative damage to cells

Lee, S. M., Koh, H., Park, D., Song, B. J., Huh, T., & Park, J. (2002) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(02)00815-8 · Cited by 422 · see citing works

Structures of Human Cytosolic NADP-dependent Isocitrate Dehydrogenase Reveal a Novel Self-regulatory Mechanism of Activity

Xu, X., Zhao, J., Xu, Z., Peng, B., Huang, Q., Arnold, E., & Ding, J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m404298200 · Cited by 407 · see citing works

Small-molecule inhibition of APT1 affects Ras localization and signaling.

Dekker, F., Rocks, O., Vartak, N., Menninger, S., Hedberg, C., Balamurugan, R., Wetzel, S., Renner, S., Gerauer, M., Schölermann, B., et al. (2010) · Nature Chemical Biology · doi:10.1038/nchembio.362 · Cited by 401 · see citing works

N-ethylmaleimide-sensitive fusion protein: a trimeric ATPase whose hydrolysis of ATP is required for membrane fusion.

Whiteheart, S. W., Rossnagel, K., Buhrow, S. A., Brunner, M., Jaenicke, R., & Rothman, J. E. (1994) · The Journal of Cell Biology · doi:10.1083/jcb.126.4.945 · Cited by 393 · see citing works

The mitochondrial intramembrane protease PARL cleaves human Pink1 to regulate Pink1 trafficking

Meißner, C., Lorenz, H., Weihofen, A., Selkoe, D. J., & Lemberg, M. K. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07253.x · Cited by 375 · see citing works

PINK1 Loss-of-Function Mutations Affect Mitochondrial Complex I Activity via NdufA10 Ubiquinone Uncoupling

Morais, V. A., Haddad, D., Craessaerts, K., Bock, P. D., Swerts, J., Vilain, S., Aerts, L., Overbergh, L., Grünewald, A., Seibler, P., et al. (2014) · Science · doi:10.1126/science.1249161 · Cited by 364 · see citing works

Proteomic analysis of normal human urinary proteins isolated by acetone precipitation or ultracentrifugation

Thongboonkerd, V., Mcleish, K. R., Arthur, J. M., & Klein, J. B. (2002) · Kidney International · doi:10.1111/j.1523-1755.2002.kid565.x · Cited by 359 · see citing works

Identification of the major Mr 100,000 substrate for calmodulin-dependent protein kinase III in mammalian cells as elongation factor-2.

Nairn, A. C., & Palfrey, H. C. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)45377-x · Cited by 341 · see citing works

Lysosomal impairment in Parkinson's disease

Dehay, B., Martinez‐Vicente, M., Caldwell, G. A., Caldwell, K. A., Yue, Z., Cookson, M. R., Klein, C., Vila, M., & Bezard, E. (2013) · Movement Disorders · doi:10.1002/mds.25462 · Cited by 340 · see citing works

Early-onset parkinsonism associated with PINK1 mutations

Bonifati, V., Rohé, C. F., Breedveld, G. J., Fabrizio, E., Mari, M. D., Tassorelli, C., Tavella, A., Marconi, R., Nicholl, D. J., Chien, H. F., et al. (2005) · Neurology · doi:10.1212/01.wnl.0000167546.39375.82 · Cited by 338 · see citing works

Redox proteomics identification of oxidized proteins in Alzheimer's disease hippocampus and cerebellum: An approach to understand pathological and biochemical alterations in AD

Rukhsana Sultana, A., Debra Boyd-kimball, A., Poon, H. F., Cai, J., Pierce, W. M. J., Klein, J. B., Merchant, M. L., Markesbery, W. R., & Butterfield, D. A. (2005) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.09.021 · Cited by 334 · see citing works

Impaired mitochondrial dynamics and function in the pathogenesis of Parkinson's disease

Büeler, H. (2009) · Experimental Neurology · doi:10.1016/j.expneurol.2009.03.006 · Cited by 326 · see citing works

Postsynaptic Decoding of Neural Activity: eEF2 as a Biochemical Sensor Coupling Miniature Synaptic Transmission to Local Protein Synthesis

Sutton, M. A., Taylor, A. M., Ito, H. T., Pham, A., & Schuman, E. M. (2007) · Neuron · doi:10.1016/j.neuron.2007.07.030 · Cited by 274 · see citing works

Collapsin Response Mediator Proteins (CRMPs): Involvement in Nervous System Development and Adult Neurodegenerative Disorders

Charrier, E., Reibel, S., Rogemond, V., Aguera, M., Thomasset, N., & Honnorat, J. (2003) · Molecular Neurobiology · doi:10.1385/mn:28:1:51 · Cited by 266 · see citing works

Characterization of PINK1 processing, stability, and subcellular localization

Lin, W., & Kang, U. J. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05398.x · Cited by 261 · see citing works

Cytoplasmic Pink1 activity protects neurons from dopaminergic neurotoxin MPTP

Haque, M. E., Craig, K. J. T., D’Souza, C. A., Callaghan, S. M., Kitada, T., Slack, R. S., Fraser, P. E., Cookson, M., Tandon, A., & Park, D. S. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0705363105 · Cited by 259 · see citing works

Localization of Phosphorylated ERK/MAP Kinases to Mitochondria and Autophagosomes in Lewy Body Diseases

Zhu, J., Guo, F., Shelburne, J. D., Watkins, S. C., & Chu, C. T. (2003) · Brain Pathology · doi:10.1111/j.1750-3639.2003.tb00478.x · Cited by 255 · see citing works

Protein degradation pathways in Parkinson’s disease: curse or blessing

Ebrahimi‐Fakhari, D., Wahlster, L., & McLean, P. J. (2012) · Acta Neuropathologica · doi:10.1007/s00401-012-1004-6 · Cited by 255 · see citing works

Voltage-dependent Anion Channels (VDACs) Recruit Parkin to Defective Mitochondria to Promote Mitochondrial Autophagy

Sun, Y., Vashisht, A. A., Tchieu, J. H., Wohlschlegel, J. A., & Dreier, L. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.419721 · Cited by 244 · see citing works

The role of calcium and mitochondrial oxidant stress in the loss of substantia nigra pars compacta dopaminergic neurons in Parkinson's disease

Surmeier, D. J., Guzman, J. N., Sanchez-Padilla, J., & Schumacker, P. T. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.08.045 · Cited by 236 · see citing works

Proteomics Analysis of the Alzheimer's Disease Hippocampal Proteome

Rukhsana Sultana, A., Debra Boyd-kimball, A., Cai, J., Pierce, W. M. J., Klein, J. B., Merchant, M. L., & Butterfield, D. A. (2007) · Journal of Alzheimer s Disease · doi:10.3233/jad-2007-11203 · Cited by 231 · see citing works

Neurotransmission in Parkinson’s disease: beyond dopamine

Barone, P. (2009) · European Journal of Neurology · doi:10.1111/j.1468-1331.2009.02900.x · Cited by 222 · see citing works

Carbonyl Reductases: The Complex Relationships of Mammalian Carbonyl- and Quinone-Reducing Enzymes and Their Role in Physiology

Oppermann, U. C. T. (2006) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.47.120505.105316 · Cited by 222 · see citing works

Depletion of PINK1 affects mitochondrial metabolism, calcium homeostasis and energy maintenance

Heeman, B., Van den Haute, C., Aelvoet, S.-A., Valsecchi, F., Rodenburg, R. J., Reumers, V., Debyser, Z., Callewaert, G., Koopman, W. J. H., Willems, P. H. G. M., et al. (2011) · Journal of Cell Science · doi:10.1242/jcs.078303 · Cited by 198 · see citing works

Caenorhabditits elegans LRK-1 and PINK-1 Act Antagonistically in Stress Response and Neurite Outgrowth

Sämann, J., Hegermann, J., von Gromoff, E. D., Eimer, S., Baumeister, R., & Schmidt, E. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m808255200 · Cited by 192 · see citing works

Pink1 regulates the oxidative phosphorylation machinery via mitochondrial fission

Liu, W., Acín-Peréz, R., Geghman, K. D., Manfredi, G., Lu, B., & Li, C. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1107332108 · Cited by 190 · see citing works

Increased Mitochondrial Calcium Sensitivity and Abnormal Expression of Innate Immunity Genes Precede Dopaminergic Defects in Pink1-Deficient Mice

Akundi, R. S., Huang, Z., Eason, J., Pandya, J. D., Zhi, L., Cass, W. A., Sullivan, P. G., & Büeler, H. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016038 · Cited by 187 · see citing works

Mitochondria mass is low in mouse substantia nigra dopamine neurons: Implications for Parkinson's disease

Liang, C., Wang, T. T., Luby‐Phelps, K., & German, D. C. (2006) · Experimental Neurology · doi:10.1016/j.expneurol.2006.08.015 · Cited by 186 · see citing works

Multifunctional roles of enolase in Alzheimer’s disease brain: beyond altered glucose metabolism

Butterfield, D. A., & Lange, M. L. B. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06397.x · Cited by 175 · see citing works

The expression of the chemorepellent Semaphorin 3A is selectively induced in terminal Schwann cells of a subset of neuromuscular synapses that display limited anatomical plasticity and enhanced vulnerability in motor neuron disease

de Winter, F., Vo, T., Stam, F. J., Wisman, L. A. B., Bär, P. R., Niclou, S. P., Muiswinkel, F. L. V., & Verhaagen, J. (2006) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2006.03.002 · Cited by 171 · see citing works

Collapsin Response Mediator Protein-2: An Emerging Pathologic Feature and Therapeutic Target for Neurodisease Indications

Hensley, K., Venkova, K. M., Christov, A., Gunning, W. T., & Park, J. C. (2011) · Molecular Neurobiology · doi:10.1007/s12035-011-8166-4 · Cited by 170 · see citing works

Reconstitution of Human Arp2/3 Complex Reveals Critical Roles of Individual Subunits in Complex Structure and Activity

Gournier, H., Goley, E. D., Niederstrasser, H., Trinh, T. M., & Welch, M. D. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00393-8 · Cited by 168 · see citing works

Milestones in PD genetics

Gasser, T., Hardy, J., & Mizuno, Y. (2011) · Movement Disorders · doi:10.1002/mds.23637 · Cited by 166 · see citing works

VDAC Channels

Blachly‐Dyson, E., & Forte, M. A. (2001) · IUBMB Life · doi:10.1080/15216540152845902 · Cited by 159 · see citing works

The voltage-dependent anion channel

Shoshan-Barmatz, V., & Gincel, D. (2007) · Cell Biochemistry and Biophysics · doi:10.1385/cbb:39:3:279 · Cited by 158 · see citing works

The role and therapeutic potential of prohibitin in disease

Theiss, A. L., & Sitaraman, S. V. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2011.01.033 · Cited by 156 · see citing works

Enhancing nucleotide metabolism protects against mitochondrial dysfunction and neurodegeneration in a PINK1 model of Parkinson’s disease

Tufi, R., Gandhi, S., de Castro, I. P., Lehmann, S., Angelova, P. R., Dinsdale, D. D., Deas, E., Plun‐Favreau, H., Nicotera, P., Abramov, A. Y., et al. (2014) · Nature Cell Biology · doi:10.1038/ncb2901 · Cited by 153 · see citing works

Dynamic Palmitoylation Links Cytosol-Membrane Shuttling of Acyl-protein Thioesterase-1 and Acyl-protein Thioesterase-2 with That of Proto-oncogene H-Ras Product and Growth-associated Protein-43

Kong, E., Peng, S., Chandra, G., Sarkar, C., Zhang, Z., Bagh, M. B., & Mukherjee, A. B. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.421073 · Cited by 153 · see citing works

Cytoplasmic Aggregates of Phosphorylated Extracellular Signal-Regulated Protein Kinases in Lewy Body Diseases

Zhu, J., Kulich, S. M., Oury, T. D., & Chu, C. T. (2002) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64487-2 · Cited by 153 · see citing works

Phosphorylation of calmodulin

Benaím, G., & Villalobo, A. (2002) · European Journal of Biochemistry · doi:10.1046/j.1432-1033.2002.03038.x · Cited by 148 · see citing works

Hsp70 Gene Transfer by Adeno-associated Virus Inhibits MPTP-Induced Nigrostriatal Degeneration in the Mouse Model of Parkinson Disease

Dong, Z., Wolfer, D. P., Lipp, H., & Büeler, H. (2004) · Molecular Therapy · doi:10.1016/j.ymthe.2004.09.007 · Cited by 148 · see citing works

A critical appraisal of the premotor symptoms of Parkinson's disease: Potential usefulness in early diagnosis and design of neuroprotective trials

Lang, A. E. (2011) · Movement Disorders · doi:10.1002/mds.23609 · Cited by 146 · see citing works

A New Cytosolic Pathway from a Parkinson Disease-associated Kinase, BRPK/PINK1

Murata, H., Sakaguchi, M., Yu, J. Z., Sakaguchi, Y. M., Futami, J., Yamada, H., Kataoka, K., & Huh, N.-H. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.179390 · Cited by 142 · see citing works

A review of the molecular basis of hypoxanthine-guanine phosphoribosyltransferase (HPRT) deficiency

Sculley, D. G., Dawson, P. A., Emmerson, B., & Gordon, R. B. (1992) · Human Genetics · doi:10.1007/bf00220062 · Cited by 137 · see citing works

The interplay of neuronal mitochondrial dynamics and bioenergetics: Implications for Parkinson's disease

Laar, V. S. V., & Berman, S. (2012) · Neurobiology of Disease · doi:10.1016/j.nbd.2012.05.015 · Cited by 133 · see citing works

From hatching to dispatching: the multiple cellular roles of the Hsp70 molecular chaperone machinery

Meimaridou, E., Gooljar, S. B., & Chapple, J. P. (2008) · Journal of Molecular Endocrinology · doi:10.1677/jme-08-0116 · Cited by 133 · see citing works

Parkin, PINK1 and mitochondrial integrity: emerging concepts of mitochondrial dysfunction in Parkinson’s disease

Pilsl, A., & Winklhofer, K. F. (2011) · Acta Neuropathologica · doi:10.1007/s00401-011-0902-3 · Cited by 128 · see citing works

Distinct Acyl Protein Transferases and Thioesterases Control Surface Expression of Calcium-activated Potassium Channels

Tian, L., McClafferty, H., Knaus, H., Ruth, P., & Shipston, M. J. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.335547 · Cited by 128 · see citing works

Nerve Growth Factor-Induced Formation of Axonal Filopodia and Collateral Branches Involves the Intra-Axonal Synthesis of Regulators of the Actin-Nucleating Arp2/3 Complex

Spillane, M., Ketschek, A., Donnelly, C. J., Pacheco, A., Twiss, J. L., & Gallo, G. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.1079-12.2012 · Cited by 128 · see citing works

Cytosolic cleaved PINK1 represses Parkin translocation to mitochondria and mitophagy

Fedorowicz, M. A., de Vries, R. L. A., Rüb, C., Becker, D., Huang, Y., Zhou, C., Wolken, D. M. A., Voos, W., Liu, Y., & Przedborski, S. (2013) · EMBO Reports · doi:10.1002/embr.201337294 · Cited by 127 · see citing works

ROLE OF CALMODULIN IN NEUROTRANSMITTER RELEASE AND SYNAPTIC FUNCTION*

DeLorenzo, R. J. (1980) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1980.tb29603.x · Cited by 124 · see citing works

Neurological Disorders of Purine and Pyrimidine Metabolism

Micheli, V., Camici, M., Tozzi, M. G., Ipata, P. L., Sestini, S., Bertelli, M., & Pompucci, G. (2011) · Current Topics in Medicinal Chemistry · doi:10.2174/156802611795347645 · Cited by 124 · see citing works

Novel Function for Receptor Activity-modifying Proteins (RAMPs) in Post-endocytic Receptor Trafficking

Bomberger, J. M., Parameswaran, N., Hall, C. S., Aiyar, N. V., & Spielman, W. S. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m413786200 · Cited by 121 · see citing works

N-ethylmaleimide sensitive factor (NSF) structure and function

Whiteheart, S. W., Schraw, T., & Matveeva, E. A. (2001) · International review of cytology · doi:10.1016/s0074-7696(01)07003-6 · Cited by 116 · see citing works

PINK1 deficiency sustains cell proliferation by reprogramming glucose metabolism through HIF1

Requejo-Aguilar, R., López-Fabuel, I., Fernández, E., Martins, L. M., Almeida, Á., & Bolaños, J. P. (2014) · Nature Communications · doi:10.1038/ncomms5514 · Cited by 112 · see citing works

Opening Pandora‘s Jar: A Primer on the Putative Roles of Crmp2 In A Panoply of Neurodegenerative, Sensory and Motor Neuron, and Central Disorders

Khanna, R., Wilson, S. M., Brittain, J. M., Weimer, J. M., Rukhsana Sultana, A., Butterfield, D. A., & Hensley, K. (2012) · Future Neurology · doi:10.2217/fnl.12.68 · Cited by 112 · see citing works

Autosomal recessive parkinsonism

Bonifati, V. (2011) · Parkinsonism & Related Disorders · doi:10.1016/s1353-8020(11)70004-9 · Cited by 105 · see citing works

Reduction of Protein Translation and Activation of Autophagy Protect against PINK1 Pathogenesis in Drosophila melanogaster

Liu, S., & Lu, B. (2010) · PLoS Genetics · doi:10.1371/journal.pgen.1001237 · Cited by 104 · see citing works

PKA Regulates Vacuolar H+-ATPase Localization and Activity via Direct Phosphorylation of the A Subunit in Kidney Cells

Alzamora, R., Thali, R. F., Gong, F., Smolak, C., Li, H., Baty, C. J., Bertrand, C. A., Auchli, Y., Brunisholz, R., Neumann, D., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.106278 · Cited by 102 · see citing works

Synaptic vesicle trafficking and Parkinson's disease

Esposito, G., Clara, F. A., & Verstreken, P. (2011) · Developmental Neurobiology · doi:10.1002/dneu.20916 · Cited by 95 · see citing works

Quantitative proteomics analysis of phosphorylated proteins in the hippocampus of Alzheimer's disease subjects

Domenico, F. D., Rukhsana Sultana, A., Barone, E., Marzia Perluigi, A., Cini, C., Mancuso, C., Cai, J., Pierce, W. M. J., & Butterfield, D. A. (2011) · Journal of Proteomics · doi:10.1016/j.jprot.2011.03.033 · Cited by 91 · see citing works

Regulation of mitochondrial permeability transition pore by PINK1

Gautier, C., Giaime, E., Caballero, E., Núñez, L., Song, Z., Chan, D. C., Villalobos, C., & Shen, J. (2012) · Molecular Neurodegeneration · doi:10.1186/1750-1326-7-22 · Cited by 91 · see citing works

Organismal proteostasis: role of cell-nonautonomous regulation and transcellular chaperone signalingPreprint

van Oosten‐Hawle, P., & Morimoto, R. I. (2014) · Genes & Development · doi:10.1101/gad.241125.114 · Cited by 91 · see citing works

Pink1 deficiency attenuates astrocyte proliferation through mitochondrial dysfunction, reduced akt and increased p38 mapk activation, and downregulation of egfr

Choi, I., Kim, J., Jeong, H., Kim, B., Jou, I., Park, S. M., Chen, L.-N., Kang, U. J., Zhuang, X., & Joe, E.-H. (2013) · Glia · doi:10.1002/glia.22475 · Cited by 88 · see citing works

Oxidative Stress in Genetic Mouse Models of Parkinson’s Disease

Varçin, M., Bentea, E., Michotte, Y. M., & Sarre, S. (2012) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2012/624925 · Cited by 84 · see citing works

Pink1-deficiency in mice impairs gait, olfaction and serotonergic innervation of the olfactory bulb

Glasl, L., Kloos, K., Giesert, F., Röthig, A. H. J., Benedetto, B. D., Kühn, R., Zhang, J., Hafen, U., Zerle, J., Hofmann, A., et al. (2012) · Experimental Neurology · doi:10.1016/j.expneurol.2012.01.002 · Cited by 83 · see citing works

Parkinson’s disease-implicated kinases in the brain; insights into disease pathogenesis

Dzamko, N. L., Zhou, J., Huang, Y. M., & Halliday, G. M. (2014) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2014.00057 · Cited by 82 · see citing works

PKN Associates and Phosphorylates the Head-Rod Domain of Neurofilament Protein

Mukai, H., Toshimori, M., Shibata, H., Kitagawa, M., Shimakawa, M., Miyahara, M., Sunakawa, H., & Ono, Y. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.16.9816 · Cited by 79 · see citing works

Mitochondrial membrane potential decrease caused by loss of PINK1 is not due to proton leak, but to respiratory chain defects

Amo, T., Sato, S., Saiki, S., Wolf, A. M., Toyomizu, M., Gautier, C., Shen, J., Ohta, S., & Hattori, N. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2010.08.027 · Cited by 79 · see citing works

Abnormal levels of prohibitin and ATP synthase in the substantia nigra and frontal cortex in Parkinson's disease

Ferrer, I., Perez, E., Dalfó, E., & Barrachina, M. (2007) · Neuroscience Letters · doi:10.1016/j.neulet.2007.01.026 · Cited by 77 · see citing works

Pathological changes in dendrites of substantia nigra neurons in Parkinson's disease: a Golgi study.

Patt, S., Gertz, H., Gerhard, L., & Cervós‐Navarro, J. (1991) · PubMed · Cited by 73 · see citing works

Ubiquitin–proteasome system dysfunction in Parkinson’s disease: current evidence and controversies

Lim, K. (2007) · Expert Review of Proteomics · doi:10.1586/14789450.4.6.769 · Cited by 72 · see citing works

Neurofilamentopathy in Neurodegenerative Diseases

Liu, Q., Xie, F., Alvarado-Diaz, A., Smith, M. A., Moreira, P. I., Zhu, X., & Perry, G. (2011) · The Open Neurology Journal · doi:10.2174/1874205x01105010058 · Cited by 72 · see citing works

Neurofilament mRNA is reduced in Parkinson's disease substantia nigra pars compacta neurons

Hill, W., Arai, M., Cohen, J. A., & Trojanowski, J. Q. (1993) · The Journal of Comparative Neurology · doi:10.1002/cne.903290304 · Cited by 71 · see citing works

Signaling pathways of prohibitin and its role in diseases

Zhou, T., & Qin, Y. (2013) · Journal of Receptors and Signal Transduction · doi:10.3109/10799893.2012.752006 · Cited by 71 · see citing works

Neuroprotective role of γ‐enolase in microglia in a mouse model of Alzheimer's disease is regulated by cathepsin X

Pišlar, A. H., Glavan, G., Obermajer, N., Živin, M., Schliebs, R., & Kos, J. (2013) · Aging Cell · doi:10.1111/acel.12093 · Cited by 69 · see citing works

A comparison of changes in proteasomal subunit expression in the substantia nigra in Parkinson's disease, multiple system atrophy and progressive supranuclear palsy

Bukhatwa, S., Zeng, B., Rose, S., & Jenner, P. G. (2010) · Brain Research · doi:10.1016/j.brainres.2010.02.045 · Cited by 65 · see citing works

Minocycline, levodopa and MnTMPyP induced changes in the mitochondrial proteome profile of MPTP and maneb and paraquat mice models of Parkinson's disease

Dixit, A., Srivastava, G., Verma, D., Mishra, M., Singh, P. K., Prakash, O., & Singh, M. P. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.03.019 · Cited by 64 · see citing works

Different functions between human monomeric carbonyl reductase 3 and carbonyl reductase 1

Miura, T., Nishinaka, T., & Terada, T. (2008) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-008-9794-5 · Cited by 60 · see citing works

Cell metabolism affects selective vulnerability in PINK1-associated Parkinson's disease

Yao, Z., Gandhi, S., Burchell, V., Plun‐Favreau, H., Wood, N. W., & Abramov, A. Y. (2011) · Journal of Cell Science · doi:10.1242/jcs.088260 · Cited by 60 · see citing works

Deficiency of the Housekeeping Gene Hypoxanthine–Guanine Phosphoribosyltransferase (HPRT) Dysregulates Neurogenesis

Guibinga, G.-H., Hsu, S. K., & Friedmann, T. (2009) · Molecular Therapy · doi:10.1038/mt.2009.178 · Cited by 55 · see citing works

Redox Proteomics Analyses of the Influence of Co-Expression of Wild-Type or Mutated LRRK2 and Tau on C. elegans Protein Expression and Oxidative Modification: Relevance to Parkinson Disease

Domenico, F. D., Rukhsana Sultana, A., Ferree, A. W., Smith, K., Barone, E., Marzia Perluigi, A., Coccia, R., Pierce, W. M. J., Cai, J., Mancuso, C., et al. (2012) · Antioxidants and Redox Signaling · doi:10.1089/ars.2011.4312 · Cited by 51 · see citing works

PINK1 enhances insulin-like growth factor-1-dependent Akt signaling and protection against apoptosis

Akundi, R. S., Zhi, L., & Büeler, H. (2011) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.08.034 · Cited by 51 · see citing works

Identification of Protein Interfaces between α-Synuclein, the Principal Component of Lewy Bodies in Parkinson Disease, and the Molecular Chaperones Human Hsc70 and the Yeast Ssa1p

Redeker, V., Pemberton, S., Bienvenut, W. V., Bousset, L., & Melki, R. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.387530 · Cited by 51 · see citing works

Proteomic analysis of brain proteins in APP/PS‐1 human double mutant knock‐in mice with increasing amyloid β‐peptide deposition: Insights into the effects of in vivo treatment with N‐acetylcysteine as a potential therapeutic intervention in mild cognitive impairment and Alzheimer's disease

Robinson, R. A. S., Gururaj Joshi, A., Huang, Q., Rukhsana Sultana, A., Baker, A. S., Cai, J., Pierce, W. M. J., Clair, D. K. S., Markesbery, W. R., & Butterfield, D. A. (2011) · PROTEOMICS · doi:10.1002/pmic.201000523 · Cited by 46 · see citing works

A subcellular analysis of genetic modulation of PINK1 on mitochondrial alterations, autophagy and cell death.

Lenzi, P., Marongiu, R., Falleni, A., Gelmetti, V., Busceti, C. L., Michiorri, S., Valente, E. M., & Fornai, F. (2012) · PubMed · doi:10.4449/aib.v150i2/3.1417 · Cited by 46 · see citing works

Brain region specific mitophagy capacity could contribute to selective neuronal vulnerability in Parkinson's disease

Diedrich, M., Kitada, T., Nebrich, G., Koppelstaetter, A., Shen, J., Zabel, C., Klose, J., & Mao, L. (2011) · Proteome Science · doi:10.1186/1477-5956-9-59 · Cited by 45 · see citing works

Ubiquitin proteasome system in Parkinson's disease: A keeper or a witness?

Martins-Branco, D. A., Esteves, A. R., Santos, D., Arduíno, D. M., Swerdlow, R. H., Oliveira, C. R., Januário, C., & Cardoso, S. M. (2012) · Experimental Neurology · doi:10.1016/j.expneurol.2012.08.008 · Cited by 44 · see citing works

GSK ‐3α/β‐mediated phosphorylation of CRMP ‐2 regulates activity‐dependent dendritic growth

Tan, M., Ma, S., Huang, Q., Hu, K., Song, B., & Li, M. (2013) · Journal of Neurochemistry · doi:10.1111/jnc.12230 · Cited by 42 · see citing works

Metabolic Control Analysis in a Cellular Model of Elevated MAO-B: Relevance to Parkinson’s Disease

Mallajosyula, J. K., Chinta, S. J., Rajagopalan, S., Nicholls, D. G., & Andersen, J. K. (2009) · Neurotoxicity Research · doi:10.1007/s12640-009-9032-2 · Cited by 42 · see citing works

PINK1 as a Molecular Checkpoint in the Maintenance of Mitochondrial Function and Integrity

Koh, H., & Chung, J. (2012) · Molecules and Cells · doi:10.1007/s10059-012-0100-8 · Cited by 40 · see citing works

Shared and Cell Type-Specific Mitochondrial Defects and Metabolic Adaptations in Primary Cells from PINK1-Deficient Mice

Akundi, R. S., Zhi, L., Sullivan, P. G., & Büeler, H. (2012) · Neurodegenerative Diseases · doi:10.1159/000345689 · Cited by 27 · see citing works

Improvement in Regional CBF by L-Serine Contributes to Its Neuroprotective Effect in Rats after Focal Cerebral Ischemia

Ren, T., Qiang, R., Jiang, Z., Wang, G., Sun, L., Jiang, R., Zhao, G.-W., & Han, L.-Y. (2013) · PLoS ONE · doi:10.1371/journal.pone.0067044 · Cited by 27 · see citing works

Mutant PINK1 upregulates tyrosine hydroxylase and dopamine levels, leading to vulnerability of dopaminergic neurons

Zhou, Z., Refai, F. S., Xie, S. P., Ng, S. H., Chan, C. H. S., Ho, P., Zhang, X. D., Lim, T. M., & Tan, E. K. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.12.015 · Cited by 27 · see citing works

The hexamerization domain of N-ethylmaleimide-sensitive factor: structural clues to chaperone function

Neuwald, A. F. (1999) · Structure · doi:10.1016/s0969-2126(99)80015-x · Cited by 22 · see citing works

R492X mutation in PTEN-induced putative kinase 1 induced cellular mitochondrial dysfunction and oxidative stress

Yuan, X.-L., Guo, J., Shi, Z., Zhi-qian, X., Yan, X., Zhao, B., & Tang, B. (2010) · Brain Research · doi:10.1016/j.brainres.2010.06.005 · Cited by 17 · see citing works

Regulation of neurite outgrowth mediated by localized phosphorylation of protein translational factor eEF2 in growth cones

Iketani, M., Iizuka, A., Sengoku, K., Kurihara, Y., Nakamura, F., Sasaki, Y., Sato, Y., Yamane, M., Matsushita, M., Nairn, A. C., et al. (2012) · Developmental Neurobiology · doi:10.1002/dneu.22058 · Cited by 17 · see citing works

Metabolic enzyme expression in dopaminergic neurons in Parkinson's disease: An in situ hybridization study

Kingsbury, A. E., Cooper, M., Schapira, A. H. V., & Foster, O. J. F. (2001) · Annals of Neurology · doi:10.1002/ana.1051 · Cited by 17 · see citing works

Identification and structural analysis of C-terminally truncated collapsin response mediator protein-2 in a murine model of prion diseases

Shinkai‐Ouchi, F., Yamakawa, Y., Hara, H., Tobiume, M., Nishijima, M., Hanada, K., & Hagiwara, K. (2010) · Proteome Science · doi:10.1186/1477-5956-8-53 · Cited by 11 · see citing works

Knockdown of cytosolic NADP+-dependent isocitrate dehydrogenase enhances MPP+-induced oxidative injury in PC12 cells

Yang, E. S., & Park, J. (2011) · BMB Reports · doi:10.5483/bmbrep.2011.44.5.312 · Cited by 9 · see citing works

Ferroptosis, a newly characterized form of cell death in Parkinson's disease that is regulated by PKC

Do Van, B., Gouel, F., Jonneaux, A., Timmerman, K., Gelé, P., Pétrault, M., Bastide, M., Laloux, C., Moreau, C., Bordet, R., et al. (2016) · Neurobiology of Disease · doi:10.1016/j.nbd.2016.05.011 · Cited by 689 · see citing works

Oligodendrocytes support axonal transport and maintenance via exosome secretion

Frühbeis, C., Kuo, W. P., Müller, C., Barth, K., Peris, L., Tenzer, S., Möbius, W., Werner, H. B., Nave, K., Fröhlich, D., et al. (2020) · PLoS Biology · doi:10.1371/journal.pbio.3000621 · Cited by 193 · see citing works

Mitochondria initiate and regulate sarcopenia

Alway, S. E., Mohamed, J. S., & Myers, M. J. (2017) · Exercise and Sport Sciences Reviews · doi:10.1249/jes.0000000000000101 · Cited by 153 · see citing works

Interactions between iron and α-synuclein pathology in Parkinson's disease

Chen, B., Wen, X., Jiang, H. F., Wang, J., Song, N., & Xie, J. (2019) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2019.06.024 · Cited by 103 · see citing works

Age-related changes in the proteostasis network in the brain of the naked mole-rat: Implications promoting healthy longevity

Triplett, J. C., Tramutola, A., Swomley, A. M., Kirk, J. M., Grimes, K. M., Hardell, K. N. L., Orr, M. E., Rodriguez, K. A., Cai, J., Klein, J. B., et al. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2015.08.002 · Cited by 73 · see citing works

The multi‐faceted role of mitochondria in the pathology of Parkinson’s disease

Trinh, D., Israwi, A. R., Arathoon, L. R., Gleave, J. A., & Nash, J. E. (2020) · Journal of Neurochemistry · doi:10.1111/jnc.15154 · Cited by 72 · see citing works

Gene networks in neurodegenerative disorders

Recabarren, D. A., & Alarcón, M. A. (2017) · Life Sciences · doi:10.1016/j.lfs.2017.06.009 · Cited by 65 · see citing works

PARK2 Mutation Causes Metabolic Disturbances and Impaired Survival of Human iPSC-Derived Neurons

Bogetofte, H., Jensen, P., Ryding, M., Schmidt, S. I., Okarmus, J., Ritter, L., Worm, C. S., Hohnholt, M. C., Azevedo, C., Roybon, L., et al. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00297 · Cited by 59 · see citing works

Phosphoregulation on mitochondria: Integration of cell and organelle responses

Lucero, M., Suarez, A. E., & Chambers, J. W. (2019) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.13141 · Cited by 58 · see citing works

Post-translational proteomics platform identifies neurite outgrowth impairments in Parkinson’s disease GBA-N370S dopamine neurons

Bogetofte, H., Ryan, B. J., Jensen, P., Schmidt, S. I., Vergoossen, D. L. E., Barnkob, M. B., Kiani, L. N., Chughtai, U., Heon‐Roberts, R., Caiazza, M. C., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112180 · Cited by 47 · see citing works

Proteasome Subunits Involved in Neurodegenerative Diseases

Fernández-Cruz, I., & Reynaud, E. (2020) · Archives of Medical Research · doi:10.1016/j.arcmed.2020.09.007 · Cited by 48 · see citing works

Quantitative Phosphoproteomic Analyses of the Inferior Parietal Lobule from Three Different Pathological Stages of Alzheimer’s Disease

Triplett, J. C., Swomley, A. M., Cai, J., Klein, J. B., & Butterfield, D. A. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-150417 · Cited by 39 · see citing works

Analysis of neuronal phosphoproteome reveals PINK1 regulation of BAD function and cell death

Wan, H., Tang, B., Liao, X., Zeng, Q., Zhang, Z., & Liao, L. (2017) · Cell Death and Differentiation · doi:10.1038/s41418-017-0027-x · Cited by 39 · see citing works

PINK1 Overexpression Promotes Cell Migration and Proliferation via Regulation of Autophagy and Predicts a Poor Prognosis in Lung Cancer Cases

Lu, X., Liu, Q., Zhang, J., Zhou, D., Yang, G., Li, M., Qiu, Y., Chen, Q., Zheng, H., & Dai, J. (2020) · Cancer Management and Research · doi:10.2147/cmar.s262466 · Cited by 36 · see citing works

Mitochondrial Protein PINK1 Positively Regulates RLR Signaling

Zhou, J., Yang, R., Zhang, Z., Liu, Q., Zhang, Y., Wang, Q., & Yuan, H. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01069 · Cited by 33 · see citing works

Knockdown of long non-coding RNA AL049437 mitigates MPP+ -induced neuronal injury in SH-SY5Y cells via the microRNA-205-5p/MAPK1 axis

Zhang, L., Wang, J.-Z., Liu, Q., Xiao, Z., & Dai, Q.-D. (2020) · NeuroToxicology · doi:10.1016/j.neuro.2020.02.004 · Cited by 33 · see citing works

Involvement of heat shock proteins on Mn-induced toxicity in Caenorhabditis elegans

Ávila, D. S., Benedetto, A., Au, C., Bornhorst, J., & Aschner, M. (2016) · BMC Pharmacology and Toxicology · doi:10.1186/s40360-016-0097-2 · Cited by 32 · see citing works

Profiles of brain oxidative damage, ventricular alterations, and neurochemical metabolites in the striatum of PINK1 knockout rats as functions of age and gender: Relevance to Parkinson disease

Ren, X., Hinchie, A., Swomley, A., Powell, D. K., & Butterfield, D. A. (2019) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2019.08.008 · Cited by 29 · see citing works

Metabolic Remodeling and Implicated Calcium and Signal Transduction Pathways in the Pathogenesis of Heart Failure

Chaanine, A. H. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221910579 · Cited by 30 · see citing works

PINK1 deficiency enhances autophagy and mitophagy induction

Gómez‐Sánchez, R., Yakhine-Diop, S. M. S., Pedro, J. M. B., Pizarro‐Estrella, E., Rodríguez‐Arribas, M., Climent, V. E., Martín‐Cano, F. E., González-Soltero, M. E., Tandon, A., Fuentes, J. M., et al. (2015) · Molecular & Cellular Oncology · doi:10.1080/23723556.2015.1046579 · Cited by 29 · see citing works

The role of charge in the toxicity of polymer-coated cerium oxide nanomaterials to Caenorhabditis elegans

Arndt, D. A., Oostveen, E. K., Triplett, J. C., Butterfield, D. A., Tsyusko, O. V., Collin, B., Starnes, D. L., Cai, J., Klein, J. B., Nass, R., et al. (2017) · Comparative Biochemistry and Physiology Part C Toxicology & Pharmacology · doi:10.1016/j.cbpc.2017.08.009 · Cited by 27 · see citing works

DJ-1 mutation decreases astroglial release of inflammatory mediators

Ashley, A. K., Hinds, A., Hanneman, W. H., Tjalkens, R. B., & Legare, M. E. (2015) · NeuroToxicology · doi:10.1016/j.neuro.2015.12.007 · Cited by 27 · see citing works

Cellular Interactome of Mitochondrial Voltage-Dependent Anion Channels: Oligomerization and Channel (Mis)Regulation

Khan, A., Kuriachan, G., & Mahalakshmi, R. (2021) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.1c00429 · Cited by 25 · see citing works

Clinical implications from proteomic studies in neurodegenerative diseases: lessons from mitochondrial proteins

Butterfield, D. A., Palmieri, E. M., & Castegna, A. (2016) · Expert Review of Proteomics · doi:10.1586/14789450.2016.1149470 · Cited by 25 · see citing works

Network Analysis Identifies Disease-Specific Pathways for Parkinson’s Disease

Monti, C., Colugnat, I., Lopiano, L., Chiò, A., & Alberio, T. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-0326-0 · Cited by 25 · see citing works

Mitochondrial Complex I Inhibition in Dopaminergic Neurons Causes Altered Protein Profile and Protein Oxidation: Implications for Parkinson’s disease

Chithra, Y., Dey, G., Ghose, V., Chandramohan, V., Gowthami, N., Vasudev, V., & Bharath, M. M. S. (2023) · Neurochemical Research · doi:10.1007/s11064-023-03907-x · Cited by 24 · see citing works

Genetic variation in neurodegenerative diseases and its accessibility in the model organism Caenorhabditis elegans

Wang, Y. A., Kammenga, J. E., & Harvey, S. C. (2017) · Human Genomics · doi:10.1186/s40246-017-0108-4 · Cited by 22 · see citing works

Competing endogenous RNA (ceRNA) networks in Parkinson's disease: A systematic review

Asadi, M. R., Abed, S., Kouchakali, G., Fattahi, F., Sabaie, H., Moslehian, M. S., Sharifi‐Bonab, M., Hussen, B. M., Taheri, M. N., Ghafouri‐Fard, S., et al. (2023) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2023.1044634 · Cited by 22 · see citing works

Identification of Potential Core Genes in Parkinson’s Disease Using Bioinformatics Analysis

Quan, W., Li, J., Jin, X., Liu, L., Zhang, Q., Qin, Y., Pei, X., & Chen, J. (2021) · Parkinson s Disease · doi:10.1155/2021/1690341 · Cited by 21 · see citing works

Quantitative Phosphoproteomic Analysis in Alpha-Synuclein Transgenic Mice Reveals the Involvement of Aberrant p25/Cdk5 Signaling in Early-stage Parkinson’s Disease

He, F., Qi, G., Zhang, Q., Cai, H., Li, T., Li, M., Zhang, Q., Chen, J., Ming, J., Tian, B., et al. (2020) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-019-00780-7 · Cited by 20 · see citing works

Proteomic studies associated with Parkinson’s disease

Kasap, M., Akpınar, G., & Kanlı, A. (2017) · Expert Review of Proteomics · doi:10.1080/14789450.2017.1291344 · Cited by 20 · see citing works

Metabolic clues to salubrious longevity in the brain of the longest‐lived rodent: the naked mole‐rat

Triplett, J. C., Swomley, A. M., Kirk, J. M., Hardell, K. N. L., Orr, M. E., Rodriguez, K. A., Cai, J., Klein, J. B., Buffenstein, R., & Butterfield, D. A. (2015) · Journal of Neurochemistry · doi:10.1111/jnc.13149 · Cited by 18 · see citing works

Molecular Alterations in the Cerebellum of Sporadic Creutzfeldt–Jakob Disease Subtypes with DJ-1 as a Key Regulator of Oxidative Stress

Tahir, W., Zafar, S., Llorens, F., Arora, A. S., Thüne, K., Schmitz, M., Gotzmann, N., Kruse, N., Mollenhauer, B., Torres, J. M., et al. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-0294-4 · Cited by 16 · see citing works

Parkin Coordinates Platelet Stress Response in Diabetes Mellitus: A Big Role in a Small Cell

Lee, S. H., Du, J., Hwa, J., & Kim, W. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21165869 · Cited by 15 · see citing works

Methyl-Arginine Profile of Brain from Aged PINK1-KO+A53T-SNCA Mice Suggests Altered Mitochondrial Biogenesis

Auburger, G. W. J., Gispert, S., & Brehm, N. (2016) · Parkinson s Disease · doi:10.1155/2016/4686185 · Cited by 15 · see citing works

Fidelity of the PINK1 knockout rat to oxidative stress and other characteristics of Parkinson disease

Ren, X., & Butterfield, D. A. (2020) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2020.12.004 · Cited by 15 · see citing works

Shining a light on defective autophagy by proteomics approaches: implications for neurodegenerative illnesses

Domenico, F. D., Zuliani, I., & Tramutola, A. (2019) · Expert Review of Proteomics · doi:10.1080/14789450.2019.1691919 · Cited by 14 · see citing works

Recent advances in applying mass spectrometry and systems biology to determine brain dynamics

Scifo, E., Calza, G., Fuhrmann, M., Soliymani, R., Baumann, M., & Lalowski, M. M. (2017) · Expert Review of Proteomics · doi:10.1080/14789450.2017.1335200 · Cited by 13 · see citing works

Proteomic Investigation of Murine Neuronal α7-Nicotinic Acetylcholine Receptor Interacting Proteins

Mulcahy, M. J., Paulo, J. A., & Hawrot, E. (2018) · Journal of Proteome Research · doi:10.1021/acs.jproteome.8b00618 · Cited by 12 · see citing works

Gel‐Based and Gel‐Free Phosphoproteomics to Measure and Characterize Mitochondrial Phosphoproteins

Thongboonkerd, V., & Chaiyarit, S. (2022) · Current Protocols · doi:10.1002/cpz1.390 · Cited by 10 · see citing works

Dusp26 phosphatase regulates mitochondrial respiration and oxidative stress and protects neuronal cell death

Eroglu, B., Jin, X., Deane, S., Öztürk, B., Ross, O. A., Moskophidis, D., & Mivechi, N. F. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04162-z · Cited by 9 · see citing works

Prohibitins in neurodegeneration and mitochondrial homeostasis

Fernandez-Abascal, J., & Artal‐Sanz, M. (2022) · Frontiers in Aging · doi:10.3389/fragi.2022.1043300 · Cited by 10 · see citing works

Evaluating the Antitumor Potential of Cannabichromene, Cannabigerol, and Related Compounds from Cannabis sativa and Piper nigrum Against Malignant Glioma: An In Silico to In Vitro Approach

Smith, A. D. T., Moreno, N. M., Rodrı́guez, J. A., Marín-Loaiza, J. C., & Bustos, G. A. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26125688 · Cited by 6 · see citing works

The many “Neurofaces” of Prohibitins 1 and 2: Crucial for the healthy brain, dysregulated in numerous brain disorders

Bernstein, H., Smalla, K., Keilhoff, G., Dobrowolny, H., Kreutz, M. R., & Steiner, J. H. (2023) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2023.102321 · Cited by 4 · see citing works

Age-Related Changes of 14-3-3 Isoforms in Midbrain of A53T-SNCA Overexpressing Mice

Brehm, N., Rau, K., Kurz, A., Gispert, S., & Auburger, G. W. J. (2015) · Journal of Parkinson s Disease · doi:10.3233/jpd-150606 · Cited by 5 · see citing works

Antioxidants and Polyphenols Mediate Mitochondrial Mediated Muscle Death Signaling in Sarcopenia

Alway, S. E. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-810422-4.00026-9 · Cited by 6 · see citing works

Mitochondrial Proteins in the Development of Parkinson’s Disease

Zilocchi, M., Fasano, M., & Alberio, T. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-8367-0_2 · Cited by 5 · see citing works

What if? Mouse proteomics after gene inactivation

Gianazza, E., Miller, I., Guerrini, U., Palazzolo, L., Laurenzi, T., Parravicini, C., & Eberini, I. (2019) · Journal of Proteomics · doi:10.1016/j.jprot.2019.03.008 · Cited by 4 · see citing works

Mechanisms and targeted intervention of mitochondria-dependent ferroptosis and abnormal ductular reaction caused by benzo(a)pyrene

Du, X., Song, S., Wang, J., Zhang, H., Ma, Y., Wang, Z., Mo, Q., Ji, M., Liu, S., Wang, Z., et al. (2025) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2025.10.001 · Cited by 2 · see citing works

Uncovering systems-level molecular similarities between Alzheimer’s and Parkinson’s diseases

Fallahi, H., Radak, M., & Yadegari, Z. S. (2023) · Neuroscience and Behavioral Physiology · doi:10.1007/s11055-023-01484-8 · Cited by 2 · see citing works

Insights into phosphoproteomic studies and prospects of phosphoproteins as biomarkers for brain disorders

Le, J., Hu, X., Jiang, Y., Wang, Q., Ma, Q., & Cui, W. (2026) · Journal of Alzheimer s Disease · doi:10.1177/13872877251411546 · Cited by 1 · see citing works

Preclinical models based on genetic mutations associated with the familial form of Parkinson's disease

Segura‐Aguilar, J. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822120-4.00009-5 · Cited by 1 · see citing works

Genetic variation associated with Alpha-synuclein pathology in Caenorhabditis elegans

Wang, Y. A. (2019) · doi:10.18174/501981

STUDIES OF OXIDATIVE DAMAGE, BRAIN PROTEOME, AND NEUROCHEMICAL METABOLITES IN COGNITIVE AND NEURODEGENERATIVE DISORDERS

Ren, X. (2020) · UKnowledge (University of Kentucky) · doi:10.13023/etd.2020.024

Recapitulating Parkinson’s disease pathology in a three-dimensional neural cell culture model

Taylor-Whiteley, T. R. (2019) · Sheffield Hallam University · doi:10.7190/shu-thesis-00321

Faculty Opinions recommendation of Oligodendrocytes support axonal transport and maintenance via exosome secretion.

Tytell, M., & Robinson, M. (2021) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.739254713.793583741

Mass spectrometry–based approaches for the identification of molecular mechanism of action of ayurvedic medicines in Parkinson disease

Hegde, A., Upadhyay, S. S., Prasad, T. S. K., & Modi, P. K. (2023) · Elsevier eBooks · doi:10.1016/b978-0-443-19084-1.00007-7

Proteomic Identification and Label-Free Quantification of Proteins Implicated in Neurite and Spine Formation

Sharma, K., Kaushal, P., & Kumar, V. (2024) · Methods in molecular biology · doi:10.1007/978-1-0716-3969-6_10

PROTEOMICS AND PHOSPHOPROTEOMICS OF BRAIN: (1) ANALYSES OF THE PINK1 KNOCKOUT MODEL OF PARKINSON DISEASE; (2) INSIGHTS INTO THE PROGRESSION OF ALZHEIMER DISEASE; AND (3) THE NAKED MOLE-RAT MODEL OF SALUBRIOUS AGING

Triplett, J. C. (2015) · UKnowledge (University of Kentucky)

Neonatal mitochondrial abnormalities due to PINK1 deficiency: Proteomics reveals early changes relevant to Parkinson׳s disease

Villeneuve, L. M., Purnell, P. R., Stauch, K. L., & Fox, H. S. (2015) · Data in Brief · doi:10.1016/j.dib.2015.11.070 · Cited by 9 · see citing works

Mammalian Target of Rapamycin Cell Signaling Pathway in Phosphatase and Tensin Homolog Induced Kinase 1 Knockout Rat Model of Familial Parkinson's Disease

Mortell, M. H. (2022) · UKnowledge (University of Kentucky)

Parkinson Phenotype in Aged PINK1-Deficient Mice Is Accompanied by Progressive Mitochondrial Dysfunction in Absence of Neurodegeneration

Gispert, S., Ricciardi, F., Kurz, A., Azizov, M., Hoepken, H.-H., Becker, D., Voos, W., Leuner, K., Müller, W. E., Kudin, A. P., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005777 · Cited by 382 · see citing works

Impact of PINK1 knockout on expression and phosphorylation of mitochondrial proteins and dopamine regulation: insight into early-stage Parkinson’s Disease in the rat model. (P3-11.014)

John, J., & Salvatore, M. F. (2023) · Neurology · doi:10.1212/wnl.0000000000202996